Boston Scientific might not scream “buy me now,” but it’s quietly flaunting strong growth credentials. The company holds a ...

Emerging markets remain a vital growth engine for Boston Scientific Corporation BSX, anchoring the company’s broader international strategy and long-term expansion plans. In the first quarter of 2025, ...

Boston Scientific is flexing its financial muscles with a strong 16.6% year-to-date gain, easily outpacing the 5.6% return of ...

Shares of Boston Scientific Corp. BSX slid 1.03% to $103.10 Tuesday, on what proved to be an all-around positive trading ...

With a market cap of $155.7 billion, Boston Scientific Corporation (BSX) is a global medical device company operating through ...

Boston Scientific has a better P/E ratio of 76.28 than the aggregate P/E ratio of 53.33 of the Health Care Equipment & Supplies industry. Ideally, one might believe that Boston Scientific Inc. might ...

Boston Scientific leads in MedSurg and Cardiovascular with strong Q1 growth, solid margins, and smart acquisitions. Find out ...